BioSpace News Archive

During its Investor Day today, senior leaders of Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will present the Company’s foundational guideposts – exceptional employees, continuous evolution and improvement, and customer and solution centric – as well as three-year financial targets.

Alpine Immune Sciences, Inc. announced that it has commenced an underwritten public offering of $100.0 million of shares of its common stock and, in lieu of shares of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its common stock, pursuant to its existing shelf registration statement.

Danaher Corporation announced that it will webcast its quarterly earnings conference call for the third quarter 2022 on Thursday, October 20, 2022 beginning at 8:00 a.m. ET and lasting approximately 1 hour.

Aditxt, Inc announced the closing of its previously announced public offering of 3,333,333 shares of its common stock, together with warrants to purchase up to 3,333,333 shares of its common stock at a combined offering price to the public of $6.00 per share and associated warrant.

Establishment Labs Holdings Inc., a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced that it will host an investor event on October 5, 2022 to discuss Mia Femtech®.

Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Versions of TAZORAC ® (tazarotene) gel, 0.05% and 0.1%, with 180 days Competitive Generic Therapy (CGT) exclusivity.